Addex Therapeutics (ADXN) Competitors $7.90 +0.04 (+0.51%) (As of 12/20/2024 05:15 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends ADXN vs. ANEB, SRZN, VRCA, IXHL, RAPT, RNXT, PMN, LIAN, DRRX, and NXTCShould you be buying Addex Therapeutics stock or one of its competitors? The main competitors of Addex Therapeutics include Anebulo Pharmaceuticals (ANEB), Surrozen (SRZN), Verrica Pharmaceuticals (VRCA), Incannex Healthcare (IXHL), RAPT Therapeutics (RAPT), RenovoRx (RNXT), ProMIS Neurosciences (PMN), LianBio (LIAN), DURECT (DRRX), and NextCure (NXTC). These companies are all part of the "pharmaceutical products" industry. Addex Therapeutics vs. Anebulo Pharmaceuticals Surrozen Verrica Pharmaceuticals Incannex Healthcare RAPT Therapeutics RenovoRx ProMIS Neurosciences LianBio DURECT NextCure Anebulo Pharmaceuticals (NASDAQ:ANEB) and Addex Therapeutics (NASDAQ:ADXN) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, community ranking, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment. Do analysts recommend ANEB or ADXN? Anebulo Pharmaceuticals currently has a consensus price target of $8.00, suggesting a potential upside of 708.08%. Addex Therapeutics has a consensus price target of $30.00, suggesting a potential upside of 279.75%. Given Anebulo Pharmaceuticals' higher probable upside, analysts clearly believe Anebulo Pharmaceuticals is more favorable than Addex Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Anebulo Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Addex Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community favor ANEB or ADXN? Addex Therapeutics received 6 more outperform votes than Anebulo Pharmaceuticals when rated by MarketBeat users. However, 90.00% of users gave Anebulo Pharmaceuticals an outperform vote while only 51.72% of users gave Addex Therapeutics an outperform vote. CompanyUnderperformOutperformAnebulo PharmaceuticalsOutperform Votes990.00% Underperform Votes110.00%Addex TherapeuticsOutperform Votes1551.72% Underperform Votes1448.28% Which has stronger earnings & valuation, ANEB or ADXN? Anebulo Pharmaceuticals has higher earnings, but lower revenue than Addex Therapeutics. Addex Therapeutics is trading at a lower price-to-earnings ratio than Anebulo Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAnebulo PharmaceuticalsN/AN/A-$8.20M-$0.30-3.30Addex Therapeutics$556.05K15.06-$11.76M-$0.34-23.24 Which has more risk & volatility, ANEB or ADXN? Anebulo Pharmaceuticals has a beta of -1.09, indicating that its share price is 209% less volatile than the S&P 500. Comparatively, Addex Therapeutics has a beta of 1.74, indicating that its share price is 74% more volatile than the S&P 500. Is ANEB or ADXN more profitable? Addex Therapeutics has a net margin of 850.30% compared to Anebulo Pharmaceuticals' net margin of 0.00%. Addex Therapeutics' return on equity of -112.43% beat Anebulo Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Anebulo PharmaceuticalsN/A -184.40% -158.14% Addex Therapeutics 850.30%-112.43%-77.95% Do institutionals & insiders believe in ANEB or ADXN? 28.4% of Anebulo Pharmaceuticals shares are owned by institutional investors. Comparatively, 16.1% of Addex Therapeutics shares are owned by institutional investors. 85.9% of Anebulo Pharmaceuticals shares are owned by company insiders. Comparatively, 15.0% of Addex Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the media prefer ANEB or ADXN? In the previous week, Anebulo Pharmaceuticals had 1 more articles in the media than Addex Therapeutics. MarketBeat recorded 1 mentions for Anebulo Pharmaceuticals and 0 mentions for Addex Therapeutics. Addex Therapeutics' average media sentiment score of 0.98 beat Anebulo Pharmaceuticals' score of 0.00 indicating that Addex Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment Anebulo Pharmaceuticals Neutral Addex Therapeutics Positive SummaryAnebulo Pharmaceuticals beats Addex Therapeutics on 8 of the 15 factors compared between the two stocks. Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Get Addex Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ADXN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ADXN vs. The Competition Export to ExcelMetricAddex TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.37M$6.57B$5.14B$9.08BDividend YieldN/A3.00%5.09%4.23%P/E Ratio-23.2310.5989.9717.18Price / Sales15.06195.801,116.21116.99Price / CashN/A57.1642.8937.86Price / Book6.585.094.784.78Net Income-$11.76M$151.83M$120.23M$225.60M7 Day Performance-1.25%-2.13%-1.92%-1.23%1 Month Performance-4.24%-3.10%11.49%3.36%1 Year Performance39.08%11.54%30.57%16.60% Addex Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ADXNAddex Therapeutics2.6993 of 5 stars$7.90+0.5%$30.00+279.7%+39.1%$8.37M$556,045.00-23.2330ANEBAnebulo Pharmaceuticals1.9538 of 5 stars$1.30-7.1%$8.00+515.4%-60.7%$33.71MN/A-4.674News CoverageGap UpHigh Trading VolumeSRZNSurrozen1.0796 of 5 stars$10.09+2.4%N/A+34.0%$32.79M$10M0.0042VRCAVerrica Pharmaceuticals4.6589 of 5 stars$0.71-6.2%$9.50+1,231.3%-89.2%$32.54M$5.12M-0.4040Analyst ForecastNews CoverageIXHLIncannex HealthcareN/A$1.83-1.6%N/A-55.1%$32.29M$86,000.00-1.343RAPTRAPT Therapeutics4.5182 of 5 stars$0.91+0.1%$9.50+942.9%-96.3%$31.85M$1.53M-0.3380RNXTRenovoRx1.2233 of 5 stars$1.28flat$6.50+407.8%+47.1%$30.72MN/A-2.256Gap UpPMNProMIS Neurosciences1.0591 of 5 stars$0.91-2.7%N/A-20.0%$29.58M$10,000.00-9.306Positive NewsLIANLianBioN/A$0.27flat$3.50+1,194.4%-94.2%$29.22MN/A-0.33110DRRXDURECT2.6264 of 5 stars$0.94+24.9%$5.00+433.9%+83.5%$29.07M$8.59M-1.3980Analyst ForecastNews CoverageNXTCNextCure4.2217 of 5 stars$1.02-5.6%$4.00+292.2%-13.4%$28.57MN/A-0.5290Positive News Related Companies and Tools Related Companies Anebulo Pharmaceuticals Alternatives Surrozen Alternatives Verrica Pharmaceuticals Alternatives Incannex Healthcare Alternatives RAPT Therapeutics Alternatives RenovoRx Alternatives ProMIS Neurosciences Alternatives LianBio Alternatives DURECT Alternatives NextCure Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ADXN) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Addex Therapeutics Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Addex Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ADXN Stock Alerts